TREPPO, Elena
 Distribuzione geografica
Continente #
NA - Nord America 228
AS - Asia 100
EU - Europa 91
AF - Africa 6
SA - Sud America 4
OC - Oceania 1
Totale 430
Nazione #
US - Stati Uniti d'America 225
SG - Singapore 76
IT - Italia 38
IE - Irlanda 13
VN - Vietnam 12
CN - Cina 8
DE - Germania 5
AR - Argentina 4
FI - Finlandia 4
NL - Olanda 4
PL - Polonia 4
RU - Federazione Russa 4
TG - Togo 4
CA - Canada 3
GB - Regno Unito 3
BE - Belgio 2
CH - Svizzera 2
FR - Francia 2
HK - Hong Kong 2
PT - Portogallo 2
SE - Svezia 2
UA - Ucraina 2
AU - Australia 1
CZ - Repubblica Ceca 1
ES - Italia 1
ET - Etiopia 1
GR - Grecia 1
IN - India 1
MA - Marocco 1
RO - Romania 1
UZ - Uzbekistan 1
Totale 430
Città #
Singapore 65
Boardman 30
Chandler 29
Dublin 13
Dong Ket 12
Ann Arbor 11
Wilmington 9
Woodbridge 9
Ashburn 8
Milan 8
Princeton 8
Fairfield 7
Udine 7
Cambridge 6
Ogden 6
Seattle 5
Amsterdam 4
Beijing 4
Houston 4
Lappeenranta 4
Lomé 4
Trieste 4
Warsaw 4
Buffalo 3
Frankfurt am Main 3
Los Angeles 3
Rosario 3
Santa Clara 3
Toronto 3
Albufeira 2
Brussels 2
Codroipo 2
Florence 2
Hong Kong 2
Jacksonville 2
Lucca 2
North Charleston 2
Pietrasanta 2
Redmond 2
St Petersburg 2
Vidnoye 2
el Pertus 2
Addis Ababa 1
Andover 1
Athens 1
Brno 1
Bucharest 1
Camden 1
Des Moines 1
Gorizia 1
Grafing 1
Hyderabad 1
Melbourne 1
Munich 1
Norwalk 1
Pamplona 1
Porcia 1
Quilmes 1
Rabat 1
Rome 1
San Diego 1
Shanghai 1
Tashkent 1
Treppo Grande 1
Venezia 1
Zhengzhou 1
Totale 329
Nome #
Data linkage analysis of giant cell arteritis in Italy: Healthcare burden and cost of illness in the Italian region of Friuli Venezia Giulia (2001–2017) 63
Efficacy and Safety of High-Dose Immunoglobulin-Based Regimen in Statin-Associated Autoimmune Myopathy: A Multi-Center and Multi-Disciplinary Retrospective Study 40
Rituximab induction and maintenance in ANCA-associated vasculitis: State of the art and future perspectives 36
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study 34
Healthcare and economic burden of ANCA-associated vasculitis in Italy: an integrated analysis from clinical and administrative databases 27
Treatment strategy introducing immunosuppressive drugs with glucocorticoids ab initio or very early in giant cell arteritis: A multicenter retrospective controlled study 27
Physical activity assessment with wearable devices in rheumatic diseases: a systematic review and meta-analysis 26
Unmet needs in ANCA-associated vasculitis: Physicians’ and patients’ perspectives 21
Rheumatologic manifestations of Hepatitis C Virus 19
Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease 18
Paraproteinemias Associated with Autoimmune Diseases 17
COVID-19 and Mixed Cryoglobulinemia Syndrome: Long-Term Survey Study on the Prevalence and Outcome, Vaccine Safety, and Immunogenicity 15
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC) 13
Safety of Biologic-DMARDs in Rheumatic Musculoskeletal Disorders: A Population-Based Study over the First Two Waves of COVID-19 Outbreak 13
Recent updates in the diagnosis and management of cryoglobulinemic vasculitis 13
Systemic vasculitis: one year in review 2024 13
Validation of the Italian version of the ANCA-associated vasculitis patient-reported outcome (AAV-PRO) questionnaire 12
Normal-Appearing Salivary Gland Ultrasonography Identifies a Milder Phenotype of Primary Sjögren's Syndrome 10
Interstitial lung disease with and without progressive fibrosing phenotype in patients with idiopathic inflammatory myopathies: data from a large multicentric cohort 10
One year in review 2020: vasculitis 9
Faster steroid-free remission with tocilizumab compared to methotrexate in giant cell arteritis: a real-life experience in two reference centres 9
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 9
The paradigm shift in ANCA-Associated vasculitis: Prime time for the complement targeting 8
Timing of rituximab and immunoglobulin level influence the risk of death for COVID-19 in ANCA-associated vasculitis 8
Systemic vasculitis: one year in review 2023 8
One year in review 2021: systemic vasculitis 8
Systemic vasculitis: one year in review 2022 8
Risk of Cancer in Connective Tissue Diseases in Northeastern Italy over 15 Years 7
The impact of two different rituximab-based strategies in cryoglobulinaemic vasculitis secondary to Sjögren's disease: a monocentric cohort study 7
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targets 7
Totale 515
Categoria #
all - tutte 4.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202021 0 0 0 0 0 0 5 4 4 4 4 0
2020/202159 1 4 6 4 0 4 3 8 8 4 4 13
2021/202258 4 2 6 4 0 0 9 6 0 10 7 10
2022/202394 10 4 11 5 10 15 0 5 15 11 4 4
2023/202498 15 10 9 3 13 3 1 4 9 11 8 12
2024/2025185 14 73 44 28 26 0 0 0 0 0 0 0
Totale 515